© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
The multi-faceted behavior of nitric oxide in vascular "inflammation": catchy terminology or true phenomenon?
Division of Cardiology, University of Perugia School of Medicine, Ospedale Silvestrini, via S. Andrea delle Fratte, 06156 Perugia, Italy
*Corresponding author. Tel.: +39-75-527-1509; fax: +39-75-527-1244. Email address: giuseppe.ambrosio@ospedale.perugia.it
Received 19 April 2004; accepted 23 April 2004
Abbreviations: NO, nitric oxide OFRs, oxygen free radicals ONOO, peroxynitrite VSMCs, vascular smooth muscle cells O2–, superoxide radical
| The first 10% of the full text of this article appears below. |
See article by Hattori et al. [11] (pages 31–40) in this issue.
Over the last 20 years, our understanding of the role of nitric oxide (NO) in biological systems has evolved enormously. Once considered merely a vasodilator (albeit a very powerful one), NO has subsequently attracted attention for its ability to modulate a number of intracellular pathways at the vascular and extravascular level. This is, however, when the headache began. The flurry of studies investigating a variety of possible cellular targets soon led to the discovery that, under different conditions, several pathophysiological events could be affected by NO by seemingly divergent mechanisms.
Initial studies pointed towards a protective effect of NO on cellular activities, indicating that NO would prevent development of the pro-atherogenic phenotype in endothelial cells and vascular smooth muscle cells, reduce leukocyte adhesion and recruitment
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
X. Liu, Y. Huang, P. Pokreisz, P. Vermeersch, G. Marsboom, M. Swinnen, E. Verbeken, J. Santos, M. Pellens, H. Gillijns, et al. Nitric Oxide Inhalation Improves Microvascular Flow and Decreases Infarction Size After Myocardial Ischemia and Reperfusion J. Am. Coll. Cardiol., August 21, 2007; 50(8): 808 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Andreadou, E. K. Iliodromitis, E. Mikros, M. Constantinou, A. Agalias, P. Magiatis, A. L. Skaltsounis, E. Kamber, A. Tsantili-Kakoulidou, and D. T. Kremastinos The Olive Constituent Oleuropein Exhibits Anti-Ischemic, Antioxidative, and Hypolipidemic Effects in Anesthetized Rabbits J. Nutr., August 1, 2006; 136(8): 2213 - 2219. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Biswas and J. B. Lopes de Faria Does peroxynitrite sustain nuclear factor-{kappa}B? Cardiovasc Res, September 1, 2005; 67(4): 745 - 746. [Full Text] [PDF] |
||||


